Site icon Kaiser Permanente | Producer

Getting our members vaccinated

A new vaccine developed by Janssen, a Johnson & Johnson company, has been approved for emergency use authorization by the Food and Drug Administration. Federal and state government health officials have not released detailed information on the distribution of the Janssen vaccine, but they expect supply to be limited at the start.

Demand for all 3 authorized vaccines will continue to outpace supply. For now, that means people eligible for vaccination will receive the type of vaccine available during their appointment.

We’re encouraged by the approval of another safe and effective vaccine to help control and eventually end the COVID-19 pandemic. We’ll keep you updated as more information becomes available.

Exit mobile version